https://www.selleckchem.com/pr....oducts/ap-3-a4-enobl
the utility of both expanded germline follow-up testing as well as germline analysis independent of tumor sequencing in appropriate patients. Palliative radiotherapy (RT) is generally recommended for older patients with esophageal squamous cell carcinoma (ESCC) with poor prognosis. A new combination treatment is therefore needed. To assess the efficacy and toxicity of RT plus icotinib vs RT alone in older patients with ESCC. This randomized, multicenter, open-label, phase II clinical trial was conducted in China, with enrollmen
Like
Comment
Share
